Ascitic fluid concentrations of cholesterol, triglycerides and phospholipids, were compared with ascitic fluid total protein in 40 patients with chronic liver disease, 51 patients with various neoplasms and 1 patient with cardiac failure. Seven patients with both chronic liver disease and malignancy were considered separately. 
chronic liver disease (4,5). Other parameters such as AF lactate dehydrogenase, carcinoembryonic antigen or fibrinogen degradation products have been investigated, but a complete separation between malignant and cirrhotic ascites has not been achieved (6-10). Lipid analysis in AF has been performed only in a few studies demonstrating elevated concentrations of total lipids as well as cholesterol in ascites of malignant origin compared to ascites caused by chronic liver disease ( 3 , l l ) .
Nevertheless, the diagnostic value of lipid determination in AF has not been evaluated further. The purpose of the present study was to investigate the efficacy of AF lipid analysis in discriminating between malignant ascites from ascites caused by cirrhosis.
MATERIALS AND METHODS
Patients. Ninety-nine consecutive ascitic patients (51 with neoplasms metastatic to the peritoneum, 40 with cirrhotic ascites and 1 with cardiac failure) were studied prospectively. Seven patients with ascites suffered from both: chronic liver disease and malignancies. As the cause of ascites could not be clearly classified, they were considered separately. The first 54 patients (23 cirrhotic and 31 with malignancy) were analyzed to determine median values and ranges and to define threshold concentrations for cholesterol, phospholipids, triglycerides and total protein between both groups. The group with chronic liver disease consisted of 12 patients with alcoholic and 10 patients with posthepatitic cirrhosis and 1 patient with Budd-Chiari syndrome. In the 31 patients with malignant ascites, there were 12 subjects with ovarian carcinoma, 11 with breast cancer and 8 with carcinoma of the pancreas, gallbladder, esophagus, stomach or uterus and peritoneal mesothelioma, teratoma and 0s-teosarcoma, respectively.
For further evaluation of the results obtained in the first 54 patients, an independent group of 38 patients (17 cirrhotic, 1 cardiac and 20 with maligancy) was studied consecutively.
Diagnoses in all patients with liver disease were confirmed by liver biopsy. Hepatic malignancy was excluded in these patients by ultrasound, scintigraphy, or computer tomography and, in some, by laparoscopy and autopsy. Patients with ascites classified as malignant had a primary or metastatic malignancy in the abdomen or pelvis. In some of these patients, the definitive diagnosis was made at autopsy.
Cytological examination was performed within 2 hr of aspiration of AF on Papanicolaou and Giemsa-stained smears of the sediment which was obtained by centrifugation of 10 to 20 mi samples at 3,000 rpm for 10 min. The supernatant was stored at -80°C for further biochemical analysis. .. (15) . .
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RESULTS
Concentrations
(1.9 gm per dl) in patients with cirrhosis ( Figure 1 Applying the discrimination values defined from the data of the first 54 patients to the 38 subsequent patients, sensitivity, specificity and efficiency were calculated (Table 2). Diagnostic efficiency ranged between 68.4 and 86.8% in this reevaluation study, and cholesterol and phospholipid determinations were superior to the other parameters. From the results of all 92 patients, an efficiency of 92.3% for cholesterol, 79.4% for phospholipids, 72.8% for triglycerides and 79.4% for protein was calculated (Table 3) . AF cholesterol measurement yielded the best discrimination: only 5 patients with malignant and 2 patients with cirrhotic ascites were incorrectly classified at a cutoff concentration of 48 mg per dl.
Cytological examination was performed in 28 of 41 patients with nonmalignant ascites and in 37 of 51 patients with ascites due to malignant neoplasms. Diagnostic specificity was found to be 100%. However, sensitivity was only 62% because of a great number of false-negative results. There was no correlation between the concentrations of triglycerides and the other lipids or total protein in AF of the 92 patients, indicating a different mechanism of triglyceride accumulation in ascites. However, Difference between the mean of cirrhotic and malignant concentrations is statistically significant, p < 0.001
Not statistically significant. (Figure 2 , a to c). Table 4 presents concentrations of AF lipids and protein found in seven patients with both chronic liver disease and malignancy. In three subjects, posthepatitic cirrhosis was the underlying disease associated with a histologically proven hepatocellular carcinoma. Low AF cholesterol levels of 5 to 11 mg per dl suggested that ascites was most likely caused by cirrhosis. In two patients suffering from cirrhosis, a hepatocellular carcinoma was suggested by ultrasound and computed tomography but not proven by histological examination. One patient had Laennec's cirrhosis and a history of carcinomas of the breast and thyroid, which had been operated successfully years ago. There was no clinical evidence of metastases. AF cytology was negative, cholesterol, protein and triglycerides were below the cutoff values and only phospholipids were slightly elevated.
Another cirrhotic suffered from an osteofibrosis, the cause of which could not clarified, but chronic myeloid leukemia could not be excluded with certainty. In the present study, we investigated the value of AF lipids in the discrimination of ascites caused by chronic liver disease and ascites due to malignancies.
In a preliminary study of 54 patients (Figure l) There was a positive correlation between AF concentrations of cholesterol, phospholipids and protein but not between these and AF triglycerides. The potential rationale for these observations is most likely an increased filtration of plasma proteins and lipoproteins in the presence of peritoneal disorders such as peritoneal carcinomatosis. In accordance with this suggestion, plasma lipoproteins have been isolated and characterized from human AF recently (16) . Although it is known that patients with cirrhosis often present low plasma cholesterol levels, this observation could not explain solely the large difference between the AF cholesterol in cirrhotic and malignant ascites. In some of the patients, plasma cholesterol and AF cholesterol were determined simultaneously. No significant difference was obtained between plasma levels of cholesterol in patients with chronic liver disease and patients with malignancies. Plasma AF gradients of cholesterol were increased in liver disease compared to malignancies due to low AF cholesterol. However, plasma-AF gradients of cholesterol did not provide a better discrimination than the AF cholesterol concentration alone.
Nevertheless, plasma AF gradients of proteins might be of greater diagnostic value than the determination of protein in AF only. In a recent study, Pare et al. (17) reported protein concentrations in cirrhotic or malignant ascites similar to those measured in our study.
Diagnostic efficiency of AF total protein determination was 80% in Pare's study as well as in our investigation.
Measurements of the AF to plasma ratio of total protein showed a similar efficiency in the discrimination of cirrhotic and malignant ascites as the determination of total AF protein alone. However, diagnostic accuracy was much higher (95%) for the plasma AF albumin gradient. In a recent study, Scholmerich et al. (18) demonstrated an excellent differentiation between malignant and nonmalignant ascites by the AF fibronectin concentration.
There is no doubt that the differential diagnosis of ascites can be improved by measurements of serum AF albumin gradient or fibronectin concentration. Our data suggest that the determination of AF cholesterol offers an equally effective discriminating test. However, the measurement of cholesterol might have considerable advantages in terms of simplicity and cost effectiveness.
As stated before, there was a positive correlation between AF concentrations of cholesterol and phospholipids, indicating a possible common mechanism of accumulation. Surprisingly, phospholipid determinations have been found less helpful for the discrimination of cirrhotic from malignant AF. This might be partially related to the method of extracting lipid from AF samples with organic solvents. Preliminary results suggest that a newly developed enzymatic method for phospholipid quantitation is more effective for this purpose (19) .
No significant correlation was observed between AF Further investigations are needed to elucidate the pathophysiology of lipid accumulations in the AF of patients with chronic liver disease, inflammatory and malignant peritoneal disorders.
